LongueVue Capital acquired Zavation Medical Products, a designer and manufacturer of spinal implants, instruments and biologics.
Here are five insights:
1. Zavation is the second medical device organization LVC has acquired within the past 18 months.
2. Zavation has a network of more than 100 distributors across 35 states. The company has commercialized over 10 product families with 10 additional novel products expected to launch over the next two years.
3. Robert W. Baird's healthcare team, led by Robert Andrews and Manish Gupta, served as exclusive financial advisors to LVC on the transaction.
4. Abacus Finance Group provided senior debt financing to Zavation in support of the transaction.
5. LVC is a private equity firm, investing in healthcare, business services, transportation and logistics, energy services and niche manufacturing.
More articles on devices and implants:
Smith & Nephew, Zimmer Biomet, NuVasive & more: 13 device company key notes
Exactech sees $67.3M in Q2 revenue; extremities revenue jumps 19% — 13 highlights
Delta Sky Magazine features Dr. Jay Jagannathan as top physician — 6 highlights